A Newcastle company is aiming to transform organ transplant procedures across the world, aided by a £1.5m boost in funding to drive its pioneering technology.
ScubaTx Limited is a pioneering healthcare spin-out from Newcastle University and Newcastle Upon Tyne Hospitals NHS Foundation Trust, whose prototype organ transportation device extends the time that human organs are viable for. The kit could ultimately revolutionise the global organ transplant system and ScubaTx is now looking to enhance its designs and develop its device following the funding, which includes investment led by the GMC Life Sciences Fund by Praetura and grant funding from Innovate UK.
ScubaTx is looking to obtain the permissions to sell its products worldwide, with a specific focus on the UK, US and mainland Europe – with an initial eye on pancreatic procedures for patients with diabetes. Founded in 2020, ScubaTx’s device taps into tech called ‘persufflation’ to deliver advanced organ preservation.
